2022
DOI: 10.1111/bph.15810
|View full text |Cite
|
Sign up to set email alerts
|

The VRAC blocker DCPIB directly gates the BK channels and increases intracellular Ca2+ in melanoma and pancreatic duct adenocarcinoma cell lines

Abstract: Background and purpose The volume regulated anion channel (VRAC) is known to be involved in different aspects of cancer cell behaviour and response to therapies. For this reason, we investigated the effect of DCPIB, a presumably specific blocker of VRAC, in two types of cancer: pancreatic duct adenocarcinoma (PDAC) and melanoma. Experimental approach We used patch‐clamp electrophysiology, supported by Ca2+ imaging, gene expression analysis, docking simulation and mutagenesis. We employed two PDAC lines (Panc‐1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 58 publications
0
19
0
Order By: Relevance
“…NS11021 decreased cell viability within 72 h. However, several lines of evidence raised serious doubts that this effect is dependent on BK activation. First, another cancer cell line (melanoma IGR37) displayed a similar viability drop after a 72 hours-long treatment with NS11021 even though the expression of the channel is ∼10 4 times lower in IGR37 cells than in Panc-1 cells ( Ferrera et al, 2021 ; Zuccolini et al, 2022 ), and no BK like currents were activated by NS11021 in IGR37 cells ( Remigante et al, 2021 ). Moreover, the other tested BK activator, NS19504, did not have any impact on Panc-1 viability in the same experimental conditions.…”
Section: Main Textmentioning
confidence: 93%
See 2 more Smart Citations
“…NS11021 decreased cell viability within 72 h. However, several lines of evidence raised serious doubts that this effect is dependent on BK activation. First, another cancer cell line (melanoma IGR37) displayed a similar viability drop after a 72 hours-long treatment with NS11021 even though the expression of the channel is ∼10 4 times lower in IGR37 cells than in Panc-1 cells ( Ferrera et al, 2021 ; Zuccolini et al, 2022 ), and no BK like currents were activated by NS11021 in IGR37 cells ( Remigante et al, 2021 ). Moreover, the other tested BK activator, NS19504, did not have any impact on Panc-1 viability in the same experimental conditions.…”
Section: Main Textmentioning
confidence: 93%
“…This splice variant is characterized by a normal BK unitary conductance of ∼250 pS but displays slower activation and higher sensitivity to [Ca 2+ ] i than its closest homolog hbr5 ( Liu et al, 2002 ). The endogenous currents displayed by Panc-1 cells at low [Ca 2+ ] i (∼20 nM) are characterized by a deviation from linearity and a sudden increase of current density at voltages ≥ +80 mV, which are likely due to the activation of BK channels ( Zuccolini et al, 2022 ). No clear evidence of LRRC26-mediated strong left shift of BK voltage-dependence can be observed in this cell line.…”
Section: Main Textmentioning
confidence: 99%
See 1 more Smart Citation
“…All reactions were performed in a 96-well format with the 7900HT Fast Real-Time PCR System (Thermo Fisher Scientific, MA, United States). The relative quantities of specific mRNA were obtained with the use of the comparative Ct method and were normalized to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) ( Maione et al, 2021 ; Zuccolini et al, 2022 ). The expression of each target gene was assessed in triplicate ( Ferrera et al, 2021 ; Maione et al, 2021 ).…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, DCPIB is not just a specific VRAC inhibitor. At concentrations used to inhibit VRAC, various studies suggested that it regulates other membrane proteins including glutamate transporter GLT-1 ( Bowens et al, 2013 ), Connexin 43 (Cx43) ( Bowens et al, 2013 ), gastric H + ,K + -ATPase ( Fujii et al, 2015 ), components of mitochondrial electron transport chains ( Afzal et al, 2019 ), K2P K + channels ( Minieri et al, 2013 ; Lv et al, 2019 ), inward rectifying K + (Kir) channels ( Deng et al, 2016 ), and BK K + channel ( Zuccolini et al, 2022 ). Nevertheless, this successful result of the structure-based approach to design DCPIB analogs suggests that further potent inhibitors targeting the native VRAC pore can be designed using the SN-407- and DCPIB-bound MmLRRC8A homo-hexamer structures in the future.…”
Section: Introductionmentioning
confidence: 99%